212 filings
Page 5 of 11
8-K
0dtug
20 Nov 20
Regulation FD Disclosure
7:30am
FWP
7n5g0w2am8fk 1n5
17 Aug 20
Free writing prospectus
4:21pm
8-K
yml4kiz0j
14 Aug 20
Entry into a Material Definitive Agreement
5:08pm
424B5
q9jbe339z4gyr549
14 Aug 20
Prospectus supplement for primary offering
5:05pm
424B5
k932 ns4kjtg
14 Aug 20
Prospectus supplement for primary offering
5:03pm
FWP
0vddr6
13 Aug 20
Free writing prospectus
6:05am
FWP
zjfyhj0 46u7cuw639
13 Aug 20
Free writing prospectus
12:00am
424B5
2s539bi3
11 Aug 20
Prospectus supplement for primary offering
5:30pm
S-3ASR
7i5980 2c
11 Aug 20
Automatic shelf registration
5:11pm
8-K
qkiu0no
10 Aug 20
Regulation FD Disclosure
7:31am
8-K
ttcwjb
22 Jun 20
Submission of Matters to a Vote of Security Holders
4:16pm
8-K
phgw7hqra
7 May 20
Seres Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Updates
7:00am
DEFA14A
wylsylv9jcgatoi
30 Apr 20
Additional proxy soliciting materials
4:13pm
8-K
b0gcm
23 Mar 20
Departure of Directors or Certain Officers
7:16am
EFFECT
ryfr1q5y8
19 Mar 20
Notice of effectiveness
12:15am
8-K
fhj hxby4kf
18 Mar 20
Entry into a Material Definitive Agreement
4:43pm